Stien De Coninck

Journal Article

Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia

Stien De Coninck (UGent) , Juliette Roels (UGent) , Béatrice Lintermans (UGent) , Sara T'Sas (UGent) and Tom Taghon

(2024) Blood Advances.

Add to list

PhD Thesis

Unravelling novel key players in T-cell acute lymphoblastic leukemia and lymphoma

Stien De Coninck (UGent)

(2024)

Add to list

Journal Article
A1
open access

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma

Stien De Coninck (UGent) , Renate De Smedt (UGent) , Béatrice Lintermans (UGent) , Lindy Reunes (UGent) , Hansen J. Kosasih, Alexandra Reekmans (UGent) , Lauren M. Brown, Nadine Van Roy (UGent) , Bruno Palhais (UGent) , Juliette Roels (UGent) , et al.

(2024) HAEMATOLOGICA. 109(5). p.1373-1384

Add to list

Journal Article
A1
open access

Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma

Lien Provez, Tom Putteman (UGent) , Mattias Landfors, Juliette Roels (UGent) , Lindy Reunes (UGent) , Sara T'Sas (UGent) , Wouter Van Loocke (UGent) , Béatrice Lintermans (UGent) , Stien De Coninck (UGent) , Morgan Thenoz, et al.

(2023) CANCERS. 15(3).

Add to list

Conference Paper
C3
open access

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

Juliette Roels (UGent) , Morgan Thénoz (UGent) , Bronislawa Szarzynska, Mattias Landfors, Stien De Coninck (UGent) , Lisa Demoen (UGent) , Lien Provez, Anna Kuchmiy (UGent) , Steven Strubbe, Lindy Reunes (UGent) , et al.

(2020) BLOOD. 136(Supplement 1).

Add to list

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

Juliette Roels (UGent) , Morgan Thénoz (UGent) , B Szarzyńska, M Landfors, Stien De Coninck (UGent) , Lisa Demoen (UGent) , Lien Provez, Anna Kuchmiy (UGent) , Steven Strubbe, Lindy Reunes (UGent) , et al.

(2020) BLOOD CANCER DISCOVERY. 1(3). p.274-289

Add to list

ZEB2 in T-cells and T-ALL

Stien De Coninck (UGent) , Geert Berx (UGent) , Tom Taghon (UGent) , Pieter Van Vlierberghe (UGent) and Steven Goossens (UGent)

(2019) ADVANCES IN BIOLOGICAL REGULATION. 74.

Academic Bibliography

Stien De Coninck

Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia

Unravelling novel key players in T-cell acute lymphoblastic leukemia and lymphoma

Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma

Pre-clinical evaluation of the hypomethylating agent decitabine for the treatment of T-cell lymphoblastic lymphoma

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

ZEB2 in T-cells and T-ALL

Contents

Support

Contact